Fig. 1
From: Frequent fragility of randomized controlled trials for HCC treatment
Example of fragility index calculation for the phase 3 trial SILIUS reported by Kudo M, et al [4]
Fig. 1 | BMC Cancer
From: Frequent fragility of randomized controlled trials for HCC treatment
Example of fragility index calculation for the phase 3 trial SILIUS reported by Kudo M, et al [4]